Home › Funds › Equitable › EQ/MFS International Intrinsic Value Portfolio
Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000062641
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,402 with, 18 against, 2 abstentions (not counted as with management); 10 items carried no recommendation. Shareholder proposals: 7 FOR, 13 AGAINST, 4 abstained, by the filing’s own vote-source field.
The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Equitable | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.1% | 1,198 | 92.5% | 339,726 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 9.6% | 3,486 |
Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Equitable funds on 24 items (2.0% of the 1,185 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Smith & Nephew plc | 2026-05-06 | Approve Performance Share Plan | For | AGAINST — 9 of 9 Equitable funds | For | — |
| Smith & Nephew plc | 2026-05-06 | Approve Remuneration Policy | For | AGAINST — 9 of 9 Equitable funds | For | — |
| Shimano, Inc. | 2026-03-24 | Shareholder Initiate Share Repurchase Program | For | AGAINST — 9 of 9 Equitable funds | Against | — |
| Shimano, Inc. | 2026-03-24 | Elect Director Shimano, Yozo | Against | FOR — 9 of 9 Equitable funds | Against | — |
| Aker BP ASA | 2026-04-21 | Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights | For | AGAINST — 8 of 8 Equitable funds | For | — |
| Knorr-Bremse AG | 2026-04-30 | Approve Remuneration Report | For | AGAINST — 7 of 7 Equitable funds | For | — |
| Knorr-Bremse AG | 2026-04-30 | Elect Reinhard Ploss to the Supervisory Board | For | AGAINST — 7 of 7 Equitable funds | For | — |
| Novonesis (Novozymes A/S) | 2026-03-23 | Reelect Heine Dalsgaard (Vice Chair) as Director | Abstain | FOR — 7 of 7 Equitable funds | Against | — |
| Novonesis (Novozymes A/S) | 2026-03-23 | Reelect Kasim Kutay Lane as Director | Abstain | FOR — 7 of 7 Equitable funds | Against | — |
| Resona Holdings, Inc. | 2026-06-24 | Elect Director Minami, Masahiro | Against | FOR — 9 of 10 Equitable funds | Against | — |
| Schneider Electric SE | 2026-05-07 | Reelect Anders Runevad as Director | For | AGAINST — 8 of 9 Equitable funds | For | — |
| Svenska Cellulosa AB SCA | 2026-03-27 | Reelect Asa Bergman as Director | For | AGAINST — 8 of 9 Equitable funds | For | — |
| Svenska Cellulosa AB SCA | 2026-03-27 | Reelect Martin Lindqvist as Director | For | AGAINST — 8 of 9 Equitable funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Approve Variable Remuneration of Executive Committee in the Amount of CHF 30.6 Million | For | AGAINST — 7 of 8 Equitable funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reappoint Fiona Druckenmiller as Member of the Compensation Committee | For | AGAINST — 7 of 8 Equitable funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reappoint Jasmine Whitbread as Member of the Compensation Committee | For | AGAINST — 7 of 8 Equitable funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reappoint Keyu Jin as Member of the Compensation Committee | For | AGAINST — 7 of 8 Equitable funds | For | — |
| Dassault Systemes SE | 2026-05-20 | Approve Compensation of Bernard Charles, Chairman of the Board | For | AGAINST — 7 of 9 Equitable funds | For | — |
| Tenaris SA | 2026-05-12 | Elect Directors (Bundled) | For | AGAINST — 4 of 5 Equitable funds | For | — |
| EssilorLuxottica SA | 2026-04-28 | Approve Compensation Report of Corporate Officers | For | AGAINST — 5 of 9 Equitable funds | For | — |
| EssilorLuxottica SA | 2026-04-28 | Approve Compensation of Francesco Milleri, Chairman and CEO | For | AGAINST — 5 of 9 Equitable funds | For | — |
| EssilorLuxottica SA | 2026-04-28 | Approve Compensation of Paul du Saillant, Vice-CEO | For | AGAINST — 5 of 9 Equitable funds | For | — |
| Aker BP ASA | 2026-04-21 | Reelect Charles Ashley Heppenstall as Director | For | AGAINST — 4 of 7 Equitable funds | For | — |
| Aker BP ASA | 2026-04-21 | Reelect Doris Reiter as Director | For | AGAINST — 4 of 7 Equitable funds | For | — |
Download all 24 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 667 | 3 |
| Capital Structure | 247 | 5 |
| Corporate Governance | 203 | 8 |
| Compensation | 196 | 2 |
| Audit-related | 82 | 0 |
| Extraordinary Transactions | 17 | 0 |
| Other Social Issues | 9 | 0 |
| Say-on-Pay | 5 | 0 |
| Other | 3 | 0 |
| Environment or Climate | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Taiwan Semiconductor Manufacturing Co., Ltd. | June 4, 2026 | $50M | 3 | 0 |
| Agilent Technologies, Inc. | March 18, 2026 | $24M | 7 | 0 |
| Waters Corporation | May 21, 2026 | $18M | 13 | 0 |
| Waters Corporation | January 27, 2026 | $17M | 2 | 0 |
| NICE Ltd. (Israel) | September 30, 2025 | $3M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 25, 2026 | Toyo Suisan Kaisha, Ltd. | Initiate Share Repurchase Program Shareholder proposal | Against | For |
| June 25, 2026 | Toyo Suisan Kaisha, Ltd. | Approve Restricted Stock Plan Shareholder proposal | Against | For |
| March 24, 2026 | Shimano, Inc. | Initiate Share Repurchase Program Shareholder proposal | For | Against |
| March 23, 2026 | Novonesis (Novozymes A/S) | Account for Ethical Policies and Ensure Compliance Frameworks in Practice Shareholder proposal | Against | For |
| June 24, 2026 | Rohto Pharmaceutical Co., Ltd. | Remove Incumbent Director Yamada, Kunio Shareholder proposal | Against | For |
| June 24, 2026 | Rohto Pharmaceutical Co., Ltd. | Amend Articles to Establish Strategic Review Committee Shareholder proposal | Against | For |
| March 24, 2026 | Ezaki Glico Co., Ltd. | Appoint Shareholder Director Nominee James B. Rosenwald III Shareholder proposal | For | Against |
| March 24, 2026 | Ezaki Glico Co., Ltd. | Appoint Shareholder Director Nominee Sano, Junichiro Shareholder proposal | For | Against |
1,432 ballot items at 89 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, EQ/MFS International Intrinsic Value Portfolio voted at 89 shareholder meetings of 84 companies, on 1,432 ballot items in all. Where management made a recommendation, the fund followed it on 98.6% of the items and voted against it 18 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 24 shareholder proposals. It voted FOR the board's own proposals more often than Equitable's funds as a whole (98.1% against 92.5%). It voted differently from most Equitable funds on 24 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.